financetom
Business
financetom
/
Business
/
Clorox Insider Sold Shares Worth $1,861,847, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clorox Insider Sold Shares Worth $1,861,847, According to a Recent SEC Filing
Sep 8, 2025 2:08 PM

04:46 PM EDT, 09/08/2025 (MT Newswires) -- Eric H Reynolds, Executive Vice President, Chief Operating Officer, on September 04, 2025, sold 15,041 shares in Clorox (CLX) for $1,861,847. Following the Form 4 filing with the SEC, Reynolds has control over a total of 54,221 common shares of the company, with 54,221 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/21076/000122520825007831/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quantum Computing Q3 Swings to Profit, Revenue Rises
Quantum Computing Q3 Swings to Profit, Revenue Rises
Nov 14, 2025
04:14 PM EST, 11/14/2025 (MT Newswires) -- Quantum Computing ( QUBT ) reported Q3 earnings late Friday of $0.01 per diluted share, swinging from a loss of $0.06 a year earlier. Three analysts surveyed by FactSet expected a loss of $0.06. Revenue for the three months ended Sept. 30 was $0.4 million, up from $0.1 million a year earlier. Three...
Sable Offshore Disputes Hunterbrook's Claims on Accounts, Bonding
Sable Offshore Disputes Hunterbrook's Claims on Accounts, Bonding
Nov 14, 2025
04:42 PM EST, 11/14/2025 (MT Newswires) -- Sable Offshore ( SOC ) on Friday disputed certain inaccuracies in a report by investment firm Hunterbrook regarding its accounts payable, ownership and bonding requirements with ExxonMobil ( XOM ) . The company clarified that its accounts payable as of September 30, was approximately $53 million, not the $163 million cited in Hunterbrook's...
Beam Global Q3 revenue misses estimates
Beam Global Q3 revenue misses estimates
Nov 14, 2025
Overview * Beam Global ( BEEM ) Q3 revenue fell 50% yr/yr, missing analyst expectations * Net loss for Q3 missed analyst estimates * Company expanded into Middle East with new joint venture Outlook * Beam Global ( BEEM ) anticipates growth from Middle East expansion due to $1 trillion infrastructure investment, in the next decade * Company expects revenue...
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Nov 14, 2025
- Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share - - Transaction expected to close in the first quarter of 2026 - - Additional portfolio monetization efforts continue - - Company reports 3Q 2025 financial results - - $112.6 million in cash and cash equivalents and marketable securities as of September 30,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved